Cingulate (CINGW) Other financing activities (2021)
Cingulate's (CINGW) quarterly Other financing activities came in at -$2.0 in Q4 2021, down 100.0% quarter-over-quarter from $3.7 million in Q3 2021.
Analysis
Cingulate (CINGW) Other financing activities (2021) Analysis & Trends
Cingulate (CINGW) has reported Other financing activities for 1 consecutive years, with -$2.0 the latest figure, recorded in Q4 2021.
- For the quarter ending Q4 2021, Other financing activities changed N/A year-over-year to -$2.0; the trailing twelve-month figure through Dec 2021 stood at $7.1 million (changed N/A YoY), and the FY2021 full-year result was $7.1 million, changed N/A from the prior year.
- Other financing activities retreated to -$2.0 in Q4 2021 per CINGW's latest filing, from $3.7 million in the prior quarter.
- Across five years, Other financing activities topped out at $3.7 million in Q3 2021 and bottomed at -$2.0 in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.46 Bn | 623.70 Bn | 17.26 Bn |
| 2 | AbbVie | 440.11 Bn | 433.54 Bn | 12.70 Bn |
| 3 | Merck | 365.04 Bn | 357.90 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn |
| 6 | Sanofi | 52.47 Bn | 45.09 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.26 Bn | 44.26 Bn | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -2.00 |
| Sep 30, 2021 | 3.73 Mn |
| Jun 30, 2021 | 1.99 Mn |
| Mar 31, 2021 | 1.39 Mn |